Business

Rep. Barragán with President Biden & Vice President Harris for Lower Prescription Drug Price Announcement

 

LARGO, MD — Rep. Nanette Barragán (CA-44) joined President Joe Biden and Vice President Kamala Harris Aug 15 for their announcement of the first negotiated drug prices under Medicare through the Inflation Reduction Act, passed by Democrats and signed by President Biden two years ago.

In a historic first, the Inflation Reduction Act allows Medicare to negotiate prescription drug prices directly with drug companies for the first time, similar to the U.S. Department of Veterans Affairs and other federal agencies that already negotiate drug prices. The new prices for the first 10 drugs selected for negotiation will take effect in Medicare beginning in 2026.

“Two years ago, President Biden, Vice President Harris, and Democrats in Congress delivered on our promise to start lowering prescription drug costs for Americans,” said Rep. Barragán. “The Inflation Reduction Act ,for the first time, gave Medicare the power to reduce the skyrocketing price of prescription drugs that disproportionately impact low-income communities and communities of color. The negotiated drug prices announced today will help millions of Americans afford their medication for diabetes, cancer, heart failure and much more. In the first year alone, this will mean $1.5 billion in out-of-pocket savings for older Americans and people with disabilities who depend on these life saving medications, including over 800,000 Californians. I was proud to join President Biden and Vice President Harris in Maryland today to celebrate this historic accomplishment, made possible by Democrats in Congress. We will continue to fight to lower costs for American families everywhere.”

The new prices of the ten drugs announced today are:

Drug Commonly Treated Conditions List Price Negotiated Price
Eliquis

 

Prevention and treatment of blood clots $521 $231
Jardiance Diabetes, heart failure, chronic kidney disease $573 $197
Xarelto Prevention and treatment of blood clots, reduction of risk for patients with coronary or peripheral artery disease $517 $197
Januvia Diabetes $527 $113
Farxiga Diabetes, heart failure, chronic kidney disease $556 $178.50
Entresto Heart failure $628 $295
Enbrel Rheumatoid arthritis, psoriasis, psoriatic arthritis $7,106 $2,355
Imbruvica Blood cancers $14,934 $9,319
Stelara Psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis $13,836 $4,695
Fiasp; NovoLog Diabetes $495 $119

 

 

Reporters Desk

Recent Posts

We 12 Kings CD Listening Party Lights Up December’s First Thursday ArtWalk

Join the listening party for this sublime Christmas album with a different spin. The eclectic…

5 days ago

Gov. Newsom Announces Judicial Appointments

  SACRAMENTO – Gov. Gavin Newsom Nov. 24 announced his appointment of six Superior Court…

6 days ago

LACDMH Launches Office of Transition Age Youth to Support Wellbeing of Teens and Young Adults

The Office of TAY's core services are provided through field-based teams; however, many other vital…

6 days ago

UPDATE 2: Unified Command Continued Response to Cargo Container Ship Fire at Port of Los Angeles

U.S. Coast Guard Southwest District  SAN PEDRO – The Unified Command continued response operations Nov.…

6 days ago

Gaslight Gazette: Synthetic Reality Big Tech’s Propaganda and the Politics of “Fake News”

Beneath all the optimistic advertising lies research that the industry would prefer to avoid. Research…

6 days ago

Nearly 5.5 Billion Gallons of Water Captured During Recent LA Storms

Stormwater capture is an important element of LADWP’s overall plan to enhance Los Angeles’ water…

6 days ago